OSTX
Price
$1.76
Change
-$0.07 (-3.83%)
Updated
Oct 21, 11:46 AM (EDT)
Capitalization
61.36M
24 days until earnings call
Intraday Buy/Sell Signals
XNCR
Price
$15.13
Change
+$0.07 (+0.46%)
Updated
Oct 21, 12:29 PM (EDT)
Capitalization
1.07B
20 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

OSTX vs XNCR

Header iconOSTX vs XNCR Comparison
Open Charts OSTX vs XNCRBanner chart's image
OS Therapies
Price$1.76
Change-$0.07 (-3.83%)
Volume$590
Capitalization61.36M
Xencor
Price$15.13
Change+$0.07 (+0.46%)
Volume$3.12K
Capitalization1.07B
OSTX vs XNCR Comparison Chart in %
OSTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OSTX vs. XNCR commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OSTX is a Hold and XNCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 21, 2025
Stock price -- (OSTX: $1.83 vs. XNCR: $15.07)
Brand notoriety: OSTX and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OSTX: 50% vs. XNCR: 174%
Market capitalization -- OSTX: $61.36M vs. XNCR: $1.07B
OSTX [@Biotechnology] is valued at $61.36M. XNCR’s [@Biotechnology] market capitalization is $1.07B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OSTX’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • OSTX’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, XNCR is a better buy in the long-term than OSTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OSTX’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 2 bullish TA indicator(s).

  • OSTX’s TA Score: 4 bullish, 5 bearish.
  • XNCR’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, OSTX is a better buy in the short-term than XNCR.

Price Growth

OSTX (@Biotechnology) experienced а -6.15% price change this week, while XNCR (@Biotechnology) price change was +7.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was +22.13%, and the average quarterly price growth was +71.28%.

Reported Earning Dates

OSTX is expected to report earnings on Nov 14, 2025.

XNCR is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($1.08B) has a higher market cap than OSTX($61.4M). XNCR YTD gains are higher at: -34.421 vs. OSTX (-57.243). OSTX has higher annual earnings (EBITDA): -13.72M vs. XNCR (-125.38M). XNCR has more cash in the bank: 444M vs. OSTX (2.8M). OSTX has less debt than XNCR: OSTX (16.7M) vs XNCR (67.9M). XNCR has higher revenues than OSTX: XNCR (147M) vs OSTX (0).
OSTXXNCROSTX / XNCR
Capitalization61.4M1.08B6%
EBITDA-13.72M-125.38M11%
Gain YTD-57.243-34.421166%
P/E RatioN/AN/A-
Revenue0147M-
Total Cash2.8M444M1%
Total Debt16.7M67.9M25%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OSTXXNCR
RSI
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 6 days ago
71%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
86%
Bullish Trend 5 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
85%
Bullish Trend 5 days ago
72%
Advances
ODDS (%)
Bullish Trend 16 days ago
88%
Bullish Trend 6 days ago
72%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 19 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
80%
Aroon
ODDS (%)
Bearish Trend 5 days ago
85%
Bullish Trend 5 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
OSTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGORX28.400.47
+1.68%
Lord Abbett Growth Opportunities R3
NBNGX26.670.30
+1.14%
Sit Mid Cap Growth
CSRIX49.860.44
+0.89%
Cohen & Steers Instl Realty Shares
DIEFX15.990.13
+0.82%
Destinations International Equity I
FSEBX14.71N/A
N/A
Fidelity Sustainable U.S. Equity

OSTX and

Correlation & Price change

A.I.dvisor tells us that OSTX and PVLA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OSTX and PVLA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OSTX
1D Price
Change %
OSTX100%
-1.08%
PVLA - OSTX
30%
Poorly correlated
+6.18%
XNCR - OSTX
23%
Poorly correlated
+2.03%
NAMS - OSTX
23%
Poorly correlated
+3.46%
ACLX - OSTX
23%
Poorly correlated
-0.25%
ADMA - OSTX
22%
Poorly correlated
+2.30%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with CRNX. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
+2.03%
CRNX - XNCR
59%
Loosely correlated
+2.12%
NUVL - XNCR
58%
Loosely correlated
+5.89%
CGON - XNCR
55%
Loosely correlated
+5.14%
DYN - XNCR
55%
Loosely correlated
+4.27%
IDYA - XNCR
54%
Loosely correlated
+4.27%
More